FineMark National Bank & Trust Makes New $255,000 Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

FineMark National Bank & Trust acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 429 shares of the biotechnology company’s stock, valued at approximately $255,000.

Other institutional investors also recently added to or reduced their stakes in the company. Public Sector Pension Investment Board increased its position in shares of Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after purchasing an additional 500 shares in the last quarter. Soros Capital Management LLC acquired a new position in Axon Enterprise during the third quarter worth approximately $630,000. Friedenthal Financial lifted its stake in Axon Enterprise by 961.7% in the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock valued at $808,000 after buying an additional 1,231 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in shares of Axon Enterprise by 33.1% in the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock valued at $54,466,000 after acquiring an additional 33,869 shares during the period. Finally, XTX Topco Ltd grew its position in shares of Axon Enterprise by 20.6% during the third quarter. XTX Topco Ltd now owns 5,650 shares of the biotechnology company’s stock worth $2,258,000 after acquiring an additional 964 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON opened at $559.06 on Thursday. The firm has a market capitalization of $42.84 billion, a PE ratio of 144.46, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average price of $591.51 and a 200 day moving average price of $546.76. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99.

Insider Buying and Selling

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on AXON shares. Needham & Company LLC reiterated a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Robert W. Baird raised their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Finally, Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.